Blog
Article
An IO census survey was administered and analyzed to better assess the current knowledge and educational needs of the oncology care delivery team.
Presented at the SITC Annual Conference, November 11 to November 14, 2020.
Authors
Janelle Schrag, MPH; Fitzgerald Draper, MS; Monique Dawkins, EdD, MPA; Lorna Lucas, MSM; Leigh M. Boehmer, PharmD, BCOP
Association of Community Cancer Centers, Rockville, Maryland, USA
Background
The landscape for clinician education in immuno-oncology (IO) has changed dramatically since the first approval of an immune checkpoint inhibitor in 2011. Educational initiatives have had to evolve with the multitude of new IO approvals and indications, as well as continuous integration of these therapies in patient care. As such, an IO census survey was administered and analyzed to better assess the current knowledge and educational needs of the oncology care delivery team.
![[Poster #490] An Immuno-Oncology Census: Assessment of Clinician Knowledge and Educational Needs in 2020](https://cdn.sanity.io/images/0vv8moc6/accc-cancer/bf862ff2f5d8946bc9444e2ce40fe806027b8c7a-470x268.png?fit=crop&auto=format)